Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
C Cordonnier, S Einarsdottir, S Cesaro… - The Lancet infectious …, 2019 - thelancet.com
Infection is a main concern after haemopoietic stem cell transplantation (HSCT) and a major
cause of transplant-related mortality. Some of these infections are preventable by …
cause of transplant-related mortality. Some of these infections are preventable by …
How I vaccinate blood and marrow transplant recipients
PA Carpenter, JA Englund - … Journal of the American Society of …, 2016 - ashpublications.org
Vaccination guidelines for recipients of blood and marrow transplantation (BMT) have been
published by 3 major societies: American Blood and Marrow Transplantation, European …
published by 3 major societies: American Blood and Marrow Transplantation, European …
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
AJ Ullmann, M Schmidt-Hieber, H Bertz, WJ Heinz… - Annals of …, 2016 - Springer
Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT)
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …
Immune reconstitution following stem cell transplantation
MRM Van Den Brink, E Velardi… - Hematology 2014, the …, 2015 - ashpublications.org
Delayed immune reconstitution after hematopoietic stem cell transplantation (HSCT) has
been associated with significant morbidity and mortality, especially after allogeneic HSCT …
been associated with significant morbidity and mortality, especially after allogeneic HSCT …
Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen.(III) Impfen bei hämatologischen und …
HJ Laws, U Baumann, C Bogdan, G Burchard… - 2020 - Springer
In Deutschland leben aktuell circa 4 Mio. Menschen, die in ihrem Leben eine
Krebserkrankung diagnostiziert bekommen haben [171]. Im Zeitraum von 1980–2017 …
Krebserkrankung diagnostiziert bekommen haben [171]. Im Zeitraum von 1980–2017 …
[HTML][HTML] Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society …
Haematopoietic stem cell transplant (HSCT) recipients have deficiencies in their adaptive
immunity against vaccine preventable diseases. National and International guidance …
immunity against vaccine preventable diseases. National and International guidance …
Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
E Gavriilaki, VT Ho, W Schwaeble, T Dudler… - … hematology & oncology, 2021 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a life-threatening syndrome that occurs in adult and pediatric patients after …
TMA) is a life-threatening syndrome that occurs in adult and pediatric patients after …
High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with …
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized
complication of hematopoietic cell transplant that can result in multi-organ failure (MOF) …
complication of hematopoietic cell transplant that can result in multi-organ failure (MOF) …
[HTML][HTML] Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide …
M Palazzo, GL Shah, O Copelan, K Seier… - Biology of Blood and …, 2018 - Elsevier
Guidelines recommend vaccination starting 12 months after autologous hematopoietic stem
cell transplant (aHCT), but there is varying practice for patients on maintenance therapy, with …
cell transplant (aHCT), but there is varying practice for patients on maintenance therapy, with …
[HTML][HTML] Terminal complement blockade after hematopoietic stem cell transplantation is safe without meningococcal vaccination
S Jodele, CE Dandoy, L Danziger-Isakov… - Biology of Blood and …, 2016 - Elsevier
Eculizumab inhibits terminal complement-mediated intravascular hemolysis in patients with
paroxysmal nocturnal hemoglobinuria and complement-mediated thrombotic …
paroxysmal nocturnal hemoglobinuria and complement-mediated thrombotic …